UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 18, 2022 4:00 P.M.
Form: S-3
CIK: 0001772028
Company Name: Scopus BioPharma Inc.
File Number: 333-261991